Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
2.720
0.00 (0.00%)
At close: Jun 12, 2026, 4:00 PM EDT
2.728
+0.008 (0.29%)
After-hours: Jun 12, 2026, 4:10 PM EDT
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $981.25 million as of June 12, 2026. Its market cap has decreased by -29.43% in one year.
Market Cap
981.25M
Enterprise Value
914.91M
1-Year Change
-29.43%
Ranking
Category
Stock Price
$2.72
Market Cap Chart
Since the IPO on November 4, 2021, Evotec SE's market cap has decreased from $9.19B to $981.25M, a decrease of -89.32%. That is a compound annual growth rate of -38.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 981.25M | -13.68% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | -8.26% |
| Nov 4, 2021 | 9.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harrow | 1.34B |
| Alvotech | 1.29B |
| Phibro Animal Health | 1.26B |
| Xeris Biopharma Holdings | 1.16B |
| Collegium Pharmaceutical | 1.13B |
| Cronos Group | 1.03B |
| Pacira BioSciences | 921.53M |
| Amphastar Pharmaceuticals | 894.65M |